Despite successful transplantation outcomes in Europe, uncontrolled organ donation after circulatory determination of death (uDCDD) has essentially been a non-starter in North America. In this paper, I identify and explore a set of interesting, ethics-related considerations that are of relevance to this organ donation-transplantation practice. The analysis provides a theoretical platform for my development of a proposal for the creation of a particular ethical practice and policy space for kidney uDCDD in the U.S. and Canada that recognizes and aims to effectively address the various, identified challenges and constraints.
Get full access to this article
View all access options for this article.
References
1.
B.Dominguez-Gil, J.Duranteau, A.Mateos, J. R.Nunez, and G.Cheissonet al., “Uncontrolled Donation after Circulatory Death: European Practices and Recommendations for the Development and Optimization of an Effective Programme,”Transplant International (2015); K. G. Munjal, S. P. Wall, L. R. Goldfrank, A. Gilbert, and B. J. Kaufman et al., “A Rationale in Support of Uncontrolled Donation After Circulatory Determination of Death,” Hastings Center Report 43, no. 1 (2013): 19-26; M. J. Reed and S. B. H. Lua, “Uncontrolled Organ Donation after Circulatory Death: Potential Donors in the Emergency Department,” Emergency Medicine Journal (2013); S. P. Wall, B. J. Kaufman, A. J. Gilbert, Y. Yushkov, and M. Goldstein et al., “Derivation of the Uncontrolled Donation after Circulatory Determination of Death Protocol for New York City,” American Journal of Transplantation 11 (2011): 1417-1426.
2.
B.Dominguez-Gil, B.Haase-Kromwijk, H.van Leiden, J.Neuberger, and L.Coeneet al., “Current Situation of Donation after Circulatory Death in European Countries,”Transplant International24 (2011): 676-686.
3.
See Munjal et al., supra note 2; Dominguez-Gil et al., supra note 1; U.S. Institute of Medicine Committee on Increasing Rates of Organ Donation, J. F.Childress, and C. T.Liverman, Organ Donation: Opportunities for Action (Washington, D.C.: National Academics Press, 2006).
4.
J.Kirby, “Ethically-Informed, Pragmatic Conditions for Organ Donation after Cardiocirculatory Death: Could They Assist in Policy Development,”Journal of Clinical Ethics24, no. 4 (2013): 373-80; see Dominguez-Gil et al., supra note 1.
5.
J. A.Akoh, “Kidney Donation after Cardiac Death,”World Journal of Nephrology1, no. 3 (2012): 79-91; Dominguez-Gil et al., supra note 1; S. P. Wall, K. G. Munjal, N. N. Dubler, and L. R. Goldfrank, “Uncontrolled Organ Donation after Circulatory Determination of Death: US Policy Failures and Call to Action,” Annals of Emergency Medicine 63, no. 4 (2014): 392-400.
6.
M. L.Volk, G. J. W.Warren, R. R.Anspach, M. P.Couper, and R. M.Merion, “Attitudes of the American Public Toward Organ Donation after Uncontrolled (Sudden) Cardiac Death,”American Journal of Transplantation10 (2010): 675-680.
7.
I.Ortega-Deballon, L.Hornby, and S. D.Shemie, “Protocols for Uncontrolled Donation after Circulatory Death: A Systematic Review of International Guidelines, Practices and Transplant Outcomes,”Critical Care19 (2015): 268.
8.
J.Wind, M.Faut, T. C.van Smaalen, and E. L. W.Heurn, “Variability in Protocols on Donation after Circulatory Death in Europe,”Critical Care17 (2013): R217.
9.
See Dominguez-Gil et al., supra note 1; Reed and Lua, supra note 1.
10.
See Ortega-Deballon et al., supra note 7; see Wind et al., supra note 8.
11.
O.Piazza, R.Romano, S.Cotena, W.Santa-niello, and E.De Robertis, “Maximum Tolerable Warm Ischaemia Time in Transplantation from Non-Heart-Beating-Donors,”Trends in Anaesthesia and Critical Care3 (2013): 72-76; J. A. Light, “The Washington, D.C. Experience with Uncontrolled Donation after Circulatory Determination of Death: Promises and Pitfalls,” Journal of Law, Medicine & Ethics 36, no. 4 (2008): 735-739; J. A. Light, D. Y. Barhyte, F. A. Gage, T. R. Sasaki, and A. O. Aquino, “Long-Term Graft Survival after Transplantation with Kidneys from Uncontrolled Nonheartbeating Donors,” Transplantation 68, no. 12 (1999): 1910-1912.
12.
D.Marquis, “Are DCD Donors Dead?”Hastings Center Report40, no. 3 (2010): 24-31; J. L. Bernat, “On Noncongruence between the Concept and Determination of Death,” Hastings Center Report 43, no. 6 (2013): 25-33.
13.
See Wind et al., supra note 8.
14.
See Marquis, supra note 12.
15.
D.Rodriguez-Arias and C.Véliz, “The Death Debates: A Call for Public Deliberation,”Hastings Center Report43, no. 6 (2013): 34-35.
16.
See Wall et al., supra note 5.
17.
C. J.Gries, D. B.White, R. D.Truog, J.Dubois, and C. C.Cosioet al., “An Official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine / Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: Ethical and Policy Considerations in Organ Donation after Circulatory Determination of Death,”American Journal of Respiratory and Critical Care Medicine188, no. 1 (2013): 103-109, at 106.
18.
See Volk et al., supra note 6; D.Rodriguez-Arias, L.Wright, and D.Paredes, “Success Factors and Ethical Challenges of the Spanish Model of Organ Donation,”The Lancet376 (2010): 1109-1111.
19.
See Wall et al., supra note 1.
20.
A.Caplan, “The Use of Prisoners as Sources of Organs – an Ethically Dubious Practice,”American Journal of Bioethics11 (2011): 1-5.
21.
See Dominguez-Gil et al., supra note 2.
22.
See Reed and Lua, supra note 1; Kirby, supra note 4.
23.
See Ortega-Deballon et al., supra note 7.
24.
See Wall et al., supra note 5; J.Wind, E. R. P.Hoogland, and L. W. E.van Heurn, “Preservation Techniques for Donors after Cardiac Death Kidneys,”Current Opinion in Organ Transplantation16 (2011): 157-161; Light, supra note 11; D. Talbot, and A. D'Alessandro, eds., Organ Donation and Transplantation after Cardiac Death (Oxford: Oxford University Press, 2009): at 273-275.
25.
See Kirby, supra note 4; Wall et al., supra note 1.
